Related Experiment Video
Updated: Jun 29, 2025

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
[Heart Failure With Preserved Ejection Fraction: A Problem Of Contemporary Cardiology]
Clara Saldarriaga-Giraldo1, Cristhian Ramírez-Ramos2, Catalina Gallego3
1Departamento de Cardiología Clínica y Falla Cardíaca, Clínica CardioVID y Universidad Pontificia Bolivariana. Docente de Cardiología Universidad de Antioquia. Medellín, Colombia. Médica internista, cardióloga y especialista en falla cardíaca. Universidad Pontificia Bolivariana Departamento de Cardiología Clínica y Falla Cardíaca Clínica CardioVID y Universidad Pontificia Bolivariana Medellín Colombia.
Abstract:
Heart failure with preserved ejection fraction (HFpEF) is a frequent and overlooked medical condition that represents a great challenge for diagnosis and treatment. Current data shows a temporal trend towards a higher prevalence of HFpEF, even above heart failure with reduced ejection fraction (HFrEF). The pathophysiology of HFpEF is heterogeneous and involves several factors such as genetics, lifestyle, and cardiac and non-cardiac comorbidities. These factors result in remodeling, maladaptation and cardiac stiffness, that later on cause dyspnea, exercise intolerance, and fatigue. Although the mortality outcome of HFpEF is as high as HFrEF, no specific therapy has demonstrated overall benefit in these patients; which is why future therapies will bet on an individualized approach according to the patients phenotype.
Related Concept Videos
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: β-Blockers
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Heart Failure Drugs: Inotropic Agents

